Browse

Oral Presentation Abstracts

S011

PERI-OPERATIVE PAIN, OPIOID USE, AND OPIOID PRESCRIPTIONS FOLLOWING INPATIENT HEAD AND NECK CANCER SURGERY

Functional Outcomes / Quality

Danielle R Trakimas, MD, MSE; Rajarsi Mandal, MD; Marietta Tan, MD; Christine G Gourin, MD, MPH; Carole Fakhry, MD, MPH; Wayne M Koch, MD; Jonathon O Russell, MD; Ralph P Tufano, MD; David W Eisele, MD; Peter S Vosler, MD, PhD

Johns Hopkins Hospital


S012

RISK FACTORS OF PATIENT-REPORTED FATIGUE AMONG LONG-TERM OROPHARYNGEAL CANCER SURVIVORS

Functional Outcomes / Quality

Puja Aggarwal, PhD, BDS, MPH1; Katherine A Hutcheson1; Ryan P Goepfert1; Adam S Garden1; Frank E Mott1; Clifton D Fuller1; Stephen Y Lai1; G. Brandon Gunn1; Ehab Y Hanna1; Erich M Sturgis2

1MD Anderson; 2Baylor College of Medicine



S014

12-MONTH SMOKING CESSATION PROGRAM LOWERS SOLUBLE CD44 LEVELS IN A HIGH-RISK POPULATION

Cancer Biology

Drew H Smith, MD, MS1; Shahm Raslan2; Isildinha M Reis, PhD1; Huaping Liu1; Jerri Halgowich1; Claudia Gordon1; Elizabeth J Franzmann, MD1

1University of Miami Leonard Miller School of Medicine; 2Florida International University Herbert Wertheim College of Medicine


S015

CRISPR-MEDIATED EPIGENETIC EDITING IDENTIFIES GENE REPRESSION PATTERNS IN HPV+ HEAD AND NECK CANCER AND MODULATES CELL GROWTH

Cancer Biology

Andrey Finegersh; Koji Ebisumoto; Sayed Sadat; Joseph Califano

UCSD


S016

COMPARISON OF THE 40-GENE EXPRESSION PROFILE TEST WITH CLINICOPATHOLOGIC RISK FACTOR-BASED ASSESSMENT TO IMPROVE METASTASIS RISK ASSESSMENT IN CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Skin Cancers

Jason G Newman, MD1; Ashley Wysong, MD2; Mary A Hall, PhD3; Christine N Bailey, MPH3; Kyle R Covington, PhD3; Sarah J Kurley, PhD3; Robert W Cook, PhD3; Chrysalyne D Schmults, MD4; Sarah T Arron, MD, PhD5

1University of Pennsylvania Health System, Philadelphia, PA; 2University of Nebraska Medical Center, Omaha, NE; 3Castle Biosciences, Inc.; 4Brigham and Women's Hospital, Boston, MA; 5University of California San Francisco, San Francisco, CA


S017

TARGETING CHEMOKINE (C-X-C MOTIF) LIGAND 17 (CXCL17) IN CUTANEOUS SQUAMOUS CELL CARCINOMA

Skin Cancers

Rafay Q Soleja, MD; Emily Zimmerman, BS; Manon Doucet; Gauri Shishodia, PhD; Tara Moore-Medlin, BS; Cherie-Ann O Nathan, MD; Alok R Khandelwal, PhD

LSU Health Sciences Center


S018

INVASION RATIO: A POTENTIAL NOVEL PROGNOSTIC METRIC FOR RISK-STRATIFYING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Skin Cancers

Moran Amit, MD, PhD; Gleber N Frederico, PhD

The University of Texas MD Anderson Cancer Center


S019

MODELING HOUSEHOLD ECONOMIC STRAIN ASSOCIATED WITH HEAD AND NECK CANCER TREATMENT: UTILIZING DATA FROM THE FEDERAL RESERVE BOARD SURVEY OF HOUSEHOLD ECONOMICS AND DECISION-MAKING

Functional Outcomes / Quality

Suparna Shah, MD1; Vivek Pandrangi, MD1; Gabriela Lilly, MD1; Matthew Herman, MSc2; Ryan Li, MD1

1Oregon Health and Science University; 2ExodusPoint


S020

LARYNGEAL CANCER TREATMENT DECISION MAKING: A CONJOINT ANALYSIS OF GENERAL PUBLIC ATTITUDES AND PRIORITIES

Functional Outcomes / Quality

Montana Upton, MD1; Neha Reddy, BA2; Mamdouh Aker, BA2; Kevin James, BA2; Marilene Wang, MD2; Abie H Mendelsohn, MD2

1Vanderbilt University Department of Otolaryngology – Head and Neck Surgery; 2UCLA Department of Head and Neck Surgery